Abstract
We aimed to estimate the frequency of overlap of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with systemic autoimmune diseases. Retrospective single-center study to identify patients with AAV diagnosis and concomitant autoimmune systemic diseases, simultaneously, before or after the diagnosis of AAV. Sociodemographic characteristics, such as comorbidities; follow-up time; type of AAV; disease duration; relapses; treatment and response; clinical, serological, and histological characteristics; disease activity and damage; prognosis; dialysis requirements, and death were assessed. Twenty-eight of two hundred and forty-seven patients (11.3%) with AAV had a concomitant diagnosis of autoimmune disease. The predominant AAV type was renal-limited vasculitis (39%), followed by granulomatosis with polyangiitis (29%), mycroscopic polyangiitis (25%), and eosinophilic granulomatosis with polyangiitis (7%). Mean age at AAV diagnosis was 50 ± 17 years and 24/28 were ANCA positive. The main clinical manifestations were renal (79%), otorhinolaryngologic (43%), and pulmonary and peripheral neuropathy (32%). Sixteen patients (57%) experienced partial or total remission at a median follow-up of 34 months, and four patients (14%) died. The most frequent autoimmune disease overlapped was rheumatoid arthritis (39%), followed by Sjögren’s syndrome and systemic sclerosis (14%), mixed connective tissue disease (11%), systemic lupus erythematosus and juvenile idiopathic arthritis (7%), and ankylosing spondylitis and IgG4-related disease (4%). In nine patients (32%), both diagnoses were simultaneous; in the rest, median time elapsed between the autoimmune disease and AAV diagnosis was 173 months. The prevalence of overlap AAV with other autoimmune diseases was low. The most common AAV phenotype was renal-limited vasculitis, and the most frequent overlap disease was rheumatoid arthritis.
Similar content being viewed by others
References
Pagnoux C (2016) Updates in ANCA-associated vasculitis. Eur J Rheumatol 3:122–133
Perez-Alamino R, Maldonado-Ficco H (2015) New insights on biomarkers in systemic vasculitis. Curr Rheumatol Rep 17:12
Rodríguez-Reyna TA, Alarcón-Segovia D (2005) Overlap syndromes in the context of shared autoimmunity. Autoimmunity 38(3):219–223
Braun MG, Csernok E, Schimitt WH, Gross WL (1996) Indicence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 23(5):826–830
Draibe J, Salama AD (2015) Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome. Springerplus 1(4):50
Foray N, Hudali T, Papireddy M, Gao J (2016) A case report describing a rare presentation of simultaneous occurrence of MPO-ANCA-associated vasculitis and rheumatoid arthritis. Case Rep Nephrol 2016:9340524
Góis M, Messias A, Carvalho D, Carvalho F, Sousa H, Sousa J, Nolasco F (2017) MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis: a case report and review of literature. J Nephropathol 6(2):58–62
Campochiaro C, Scotti R, Margari S, Giorgione V, Mellone R, Mangili G, del Maschio A, Tresoldi M (2016) A case of granulomatosis with polyangiitis: rheumatoid arthritis overlap syndrome presenting as cervical cancer successfully treated with rituximab. Intern Med J 46(6):745–746
Wedderburn LR, Kwan JT, Thompson PW, Rudge SR (1992) Juvenile chronic arthiritis and Wegener’s granulomatosis. Br J Rheumatol 31(2):121–123
Dhib M, Prieur AM, Courville S, Niaudet P, Francois A, Godin M, Fillastre JP (1996) Crescentic glomerulonephritis in juvenile chronic arthritis. J Rheumatol 23(9):1636–1640
Jakez-Ocampo J, Ramírez J, Paulín-Vera CM, Flores-Suárez LF, Reyes E, Llorente L (2010) Juvenile idiopathic arthritis and Wegener’s granulomatosis—causal or casual acquaintances? Joint Bone Spine 77(4):349–350
Belot A, Bader-Meunier B, Niaudet P, Salomon R, Prieur AM, Noel LH, Quartier P (2012) ANCA-associated glomerulonephritis in systemic-onset juvenile idiopathic arthritis. Am J Kidney Dis 59(3):439–443
Ooi KG, Drummond SR, Thompson KJ, Roberts F, Kemp EG (2004) Churg-Strauss syndrome presenting with conjunctival nodules in association with Candida albicans and ankylosing spondylitis. Clin Exp Opththalmol 32(4):441–443
Calvo-Romero JM, Romero-Requena J, Arévalo-Lorido JC (2003) Antineutrophil cytoplasmic antibodies (ANCA) in ankylosing spondylitis. Clin Exp Rheumatol 21(4):528
Yu F, Tan Y, Liu G, Wang SX, Zou WZ, Zhao MH (2009) Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 76(3):307–317
Sen D, Isenberg DA (2003) Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12:651–658
Jarrot PA, Chiche L, Hervier B, Daniel L, Vuiblet V, Bardin N, Bertin D, Terrier B, Amoura Z, Andrés E, Rondeau E, Hamidou M, Pennaforte JL, Halfon P, Daugas E, Dussol B, Puéchal X, Kaplanski G, Jourde-Chiche N (2016) Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis. Medicine (Baltimore) 95(22):e3748
Guellec D, Cornec-Le Gall E, Groh M et al (2015) ANCA-associated vasculitis in patients with primary Sjögren’s syndrome: detailed analysis of 7 new cases and systematic literature review. Autoimmun Rev 14(8):742–750
Font J, Ramos-Casals M, Cervera R et al (1998) Antineutrophil cytoplasmic antibodies in primary Sjögren’s syndrome: prevalence and clinical significance. Br J Rheumatol 37(12):1287–1291
Kubota K, Ueno T, Mise K, Hazue R, Suwabe T, Kikuchi K, Hoshino J, Sumida K, Hayami N, Takaichi K, Fujii T, Ohashi K, Nonomura Y, Ubara Y (2015) ANCA-associated vasculitis in a patient with systematic sclerosis and Sjögren’s syndrome: a case report. Case Rep Nephrol Dial 5(2):113–117
Ghorbel IB, Feki NB, Salem TB, Hamzaoui A, Khanfir M, Lamloum M, Miled M, Houman MH (2015) Microscopic polyangiitis associated with primary biliary cirrhosis, Sjogren’s syndrome and Hashimoto’s thyroiditis. Saudi J Kidney Dis Transpl 26(2):359–362
Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R (2003) Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol 30(6):1248–1252
Akimoto S, Ishikawa O, Tamura T et al (1996) Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis. Br J Dermatol 134(3):407–410
Derrett-Smith EC, Nihtyanova SI, Harvey J, Salama AD, Denton CP (2013) Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. Rheumatology (Oxford) 52(10):1824–1831
Quéméneur T, Mouthon L, Cacoub P, Meyer O, Michon-Pasturel U, Vanhille P, Hatron PY, Guillevin L, Hachulla E (2013) Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature. Medicine (Baltimore) 92(1):1–9
Guilpain P, Chéreau C, Goulvestre C et al (2011) The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis. Eur Respir J 37(6):1503–1513
Tubery A, Fortenfant F, Combe B, Abreu I, Bossuyt X, Chretien P, Desplat-Jégo S, Fabien N, Hue S, Johanet C, Lakomy D, Vincent T, Daïen CI (2016) Clinical association of mixed connective tissue disease and granulomatosis with polyangiitis: a case report and systematic screening of anti-U1RNP and anti-PR3 auto-antibody double positivity in ten European hospitals. Immunol Res 64(5–6):1243–1246
Hernández-Molina G, Reyes E, Crispín JC (2006) ANCA associated glomerulonephritis in a patient with mixed connective tissue disease. Ann Rheum Dis 65(3):410–411
Ando M, Goto A, Yamasue M, Usagawa Y, Oka H, Shigenaga T, Kadota JI et al (2017) Pulmonary-limited granulomatosis with polyangiitis coexisting with mixed connective tissue disease. Tohoku J Exp Med 242(2):109–114
Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, Yi ES (2013) IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol 44(11):2432–2437
Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, Guillevin L, Vaglio A, Terrier B, French Vasculitis Study Group (2017) Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16(10):1036–1043
Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, Bhalodia A, Sohani AR, Zhang L, Chari S, Sethi S, Fidler ME, Cornell LD (2011) IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 22(7):1343–1352
Della-Torre E, Lanzillotta M, Campochiaro C, Bozzalla E, Bozzolo E, Bandiera A, Bazzigaluppi E, Canevari C, Modorati G, Stone JH, Manfredi A, Doglioni C (2016) Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature. Medicine (Baltimore) 95(34):e4633
Rincón JF, Cano DL, Morales SJ et al (2016) The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico. Clin Rheumatol 35(6):1457–1462
Zenteno JC, Correa-Gómez V, Pompa-Mera EN, Lima G, Pedroza-Seres M, Flores-Suárez LF (2016) The PTPN22 R620W polymorphism in anti-neutrophil cytoplasmic antibody-associated vasculitis in Mexican Mestizos. Rheumatology (Oxford) 55(12):2271–2273
Menegatti E, Davit A, Francica S, Berardi D, Rossi D, Baldovino S, Tovo PA, Sena LM, Roccatello D (2009) Genetic factors associated with rheumatoid arthritis and systemic vasculitis: evaluation of a panel of polymorphisms. Dis Markers 27(5):217–223
Weckmann AL, Granados J, Cardiel MH, Andrade F, Vargas-Alarcón G, Alcocer-Varela J, Alarcón-Segovia D (1999) Immunogenetics of mixed connective tissue disease in a Mexican Mestizo population. Clin Exp Rheumatol 17(1):91–94
Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DRW, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JSF, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KGC (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367(3):214–223
Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86(4):242–251
Bienaimé F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP (2007) D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am J Kidney Dis 50(5):821–825
Acknowledgements
No acknowledgements to report.
Author information
Authors and Affiliations
Contributions
EMN and AHA designed the study; EMN and DZT participated in acquisition of data; AHA analyzed and interpreted data; EMN and AHA drafted the manuscript; EMN, DZT, and AHA revised the manuscript.
Corresponding author
Ethics declarations
Research was conducted in compliance with the Helsinki Declaration. Informed consent was not obtained due to the retrospective nature of the study and no need for approval by the local ethical committee was needed.
Disclosure
None.
Ethical standards statement
The manuscript does not contain clinical studies or patient data.
Electronic supplementary material
ESM 1
(PDF 151 kb)
Rights and permissions
About this article
Cite this article
Martín-Nares, E., Zuñiga-Tamayo, D. & Hinojosa-Azaola, A. Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity. Clin Rheumatol 38, 97–106 (2019). https://doi.org/10.1007/s10067-018-4212-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-018-4212-1